Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorLopez-Rodriguez, Juan A.
dc.contributor.authorRogero-Blanco, Eloísa
dc.contributor.authorAza-Pascual-Salcedo, Mercedes
dc.contributor.authorLopez-Verde, Fernando
dc.contributor.authorPico-Soler, Victoria
dc.contributor.authorLeiva-Fernandez, Francisca
dc.contributor.authorPrados-Torres, J. Daniel
dc.contributor.authorPrados-Torres, Alexandra
dc.contributor.authorCura-González, Isabel
dc.contributor.authorMULTIPAP group
dc.contributor.authorAzcoaga-Lorenzo, Amaya
dc.date.accessioned2020-09-16T09:30:04Z
dc.date.available2020-09-16T09:30:04Z
dc.date.issued2020-08-12
dc.identifier.citationLopez-Rodriguez , J A , Rogero-Blanco , E , Aza-Pascual-Salcedo , M , Lopez-Verde , F , Pico-Soler , V , Leiva-Fernandez , F , Prados-Torres , J D , Prados-Torres , A , Cura-González , I , MULTIPAP group & Azcoaga-Lorenzo , A 2020 , ' Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP : a cross-sectional study ' , PLoS One , vol. 15 , no. 8 , e0237186 . https://doi.org/10.1371/journal.pone.0237186en
dc.identifier.issn1932-6203
dc.identifier.otherPURE: 269967756
dc.identifier.otherPURE UUID: 5f17d0f4-479e-420a-ab2a-02ac078922c1
dc.identifier.otherScopus: 85089408219
dc.identifier.otherORCID: /0000-0003-3307-878X/work/79918447
dc.identifier.urihttp://hdl.handle.net/10023/20629
dc.description.abstractBackground Multimorbidity is a global health challenge that is associated with polypharmacy, increasing the risk of potentially inappropriate prescribing (PIP). There are tools to improve prescription, such as implicit and explicit criteria. Objective To estimate the prevalence of PIP in a population aged 65 to 74 years with multimorbidity and polypharmacy, according to American Geriatrics Society Beers Criteria® (2015, 2019), the Screening Tool of Older Person’s Prescription -STOPP- criteria (2008, 2014), and the Medication Appropriateness Index -MAI- criteria in primary care. Methods This was an observational, descriptive, cross-sectional study. The sample included 593 community-dwelling elderly aged 65 to 74 years, with multimorbidity and polypharmacy, who participated in the MULTIPAP trial. Socio-demographic, clinical, professional, and pharmacological-treatment variables were recorded. Potentially inappropriate prescribing was detected by computerized prescription assistance system, and family doctors evaluated the MAI. The MAI-associated factors were analysed using a logistic regression model. Results A total of 4,386 prescriptions were evaluated. The mean number of drugs was 7.4 (2.4 SD). A total of 94.1% of the patients in the study had at least one criterion for drug inappropriateness according to the MAI. Potentially inappropriate prescribing was detected in 57.7%, 43.6%, 68.8% and 71% of 50 patients according to the explicit criteria STOPP 2014, STOPP 2008, Beers 2019 and Beers 2015 respectively. For every new drug taken by a patient, the MAI score increased by 2.41 (95% CI 1.46; 3.35) points. Diabetes, ischaemic heart disease and asthma were independently associated with lower summated MAI scores.   Conclusions The prevalence of potentially inappropriate prescribing detected in the sample was high and in agreement with previous literature for populations with multimorbidity and polypharmacy. The MAI criteria detected greater inappropriateness than did the explicit criteria, but their application was more complex and difficult to automate.
dc.format.extent20
dc.language.isoeng
dc.relation.ispartofPLoS Oneen
dc.rightsCopyright: © 2020 Lopez-Rodriguez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.subjectRM Therapeutics. Pharmacologyen
dc.subjectDASen
dc.subject.lccRMen
dc.titlePotentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP : a cross-sectional studyen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Medicineen
dc.contributor.institutionUniversity of St Andrews.Population and Behavioural Science Divisionen
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0237186
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record